Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.053
▾0.001 (1.92%)
Last trade: 20/12, 7:54PM
Market cap
$24.36m
Market closed
Talk to Resonance Health Limited directly.
Sign up to their Investor Hub for direct access to the Resonance Health Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Resonance Health Limited (RHT) is an Australian healthcare company specialised in development and commercialisation of magnetic resonance imaging (MRI) related technology for diagnosis and management of human disease. The company has representatives in Australia, UK, Germany and the USA and a distributor in Turkey, the UAE, Saudi Arabia and Egypt. RHT's lead product is FerriScan, a non-invasive test for liver iron concentration. Former Names Geo2 Limited (GEL) 12/12/2003; Accel Industrial & Mineral Processes Ltd (AIN), 16/04/1996.
Address
Suite 2, Level G/141 Burswood Rd, Burswood WA 6100, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.053
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.